Geographic Atrophy Patient with Declining Vision Exploring Treatment Options

Opinion
Video

Katherine Talcott, MD, presents the case of a 64-year-old woman with geographic atrophy and a family history of age-related macular degeneration.

Current Time 0:00
Duration 6:53
Loaded: 0%
Stream Type LIVE
Remaining Time 6:53
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Supported in part by ZEISS Professional Education. Content independently developed by Eye Care Network.

    Recent Videos
    Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
    EnVision Summit 2025: The latest in retina discussion on the books
    From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
    What's in store for optometrists in 2025 and beyond?
    EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
    EnVision Summit 2025: Meet the faculty
    What was the biggest innovation in eye care in 2024?
    2024 in the rearview: What was the biggest development in optometry this year?
    Dr Carolyn Majcher chats about GA and posterior uveitis at AAOpt 2024
    AAOpt 2024: Early detection and thorough imaging are the key to vision preservation in geographic atrophy
    David Chin Yee, MD, at EyeCon 2024
    EyeCon 2024: What optometrists need to know about geographic atrophy
    Dr. Adam Wenick at EyeCon 2024
    EyeCon 2024: New treatments in geographic atrophy from detection to intervention
    Katherine Talcott, MD, presenting slides
    A Case of a Geographic Atrophy Patient Needing Low Vision Rehabilitation
    Emily Chew, MD, outlines her lecture that landed her the Proctor Award at ARVO 2024
    ARVO 2024: Tackling the epidemic of AMD and reintroducing prevention strategies with this year's Proctor Award Lecture winner
    CIME 2024: Outlining the new standard of care in geographic atrophy
    CIME 2024: Outlining the new standard of care in geographic atrophy
    Related Content
    CDR-Life completes fifth milestone and is recruiting patients for phase 2 geographic atrophy study - Image credit: Adobe Stock / ©Parradee

    CDR-Life completes fifth milestone and is recruiting patients for Phase 2 study of BI 771716

    Sydney M Crago, Editor, Modern Retina
    March 18th 2025
    Article
    Advances in treatment for geographic atrophy

    Advances in treatment for geographic atrophy

    David S. Boyer, MD;Tina Mac Donald, OD, CDCES, FAAO;Leo P. Semes, OD, FAAO
    October 11th 2023
    Podcast
    Woman in scrubs holding a pill and glass of water Image credit: AdobeStock/NewAfrica

    Cognition Therapeutics announces manuscript publication on oral drug candidate zervimesine (CT1812) for treatment of dry AMD

    Jordana Joy, Associate Editor
    February 28th 2025
    Article
    optos MonacoPro captures retinal images in a patient with myopia - Image credit: Optos

    Optos ushers in new generation of imaging with MonacoPro ultra-widefield and OCT

    Emily Kaiser Maharjan, Assistant Managing Editor
    February 19th 2025
    Article
    FDA approved amended label for avacincaptad pegol (Izervay) - Image credit: Adobe Stock / ©Araki Illustrations

    FDA approves amended label for Izervay for geographic atrophy

    Emily Kaiser Maharjan, Assistant Managing Editor
    February 13th 2025
    Article
    woman with geographic atrophy participates in preclinical trial to reduce retinal cell death via ophthalmic topical gel - Image credit: Adobe Stock / ©K Davis/peopleimages.com

    SeaBeLife announces preclinical efficacy results for SBL03 topical ophthalmic gel

    Hattie Hayes
    February 6th 2025
    Article
    © 2025 MJH Life Sciences

    All rights reserved.